How I approach smoldering multiple myeloma

Iuliana Vaxman, Morie A. Gertz

Research output: Contribution to journalReview articlepeer-review

Abstract

The current standard of care in smoldering multiple myeloma (SMM) is close surveillance, outside of clinical trials. Efforts are being made to understand the pathobiologic process that leads to the progression of SMM to active MM. This review provides a critical description of available data, including risk factors and risk models of progression, as well as clinical trials investigating interventions for this patient population. We describe 2 cases in which patients were seen before the concept of a myeloma-defining event was established. Today, based on the International Myeloma Working Group criteria, both patients would have been identified as experiencing myeloma-defining events, and therapy would have been initiated. These cases show that occasionally, patients can undergo observation only, even when they exceed criteria for high-risk SMM.

Original languageEnglish (US)
Pages (from-to)828-838
Number of pages11
JournalBlood
Volume140
Issue number8
DOIs
StatePublished - Aug 25 2022

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint

Dive into the research topics of 'How I approach smoldering multiple myeloma'. Together they form a unique fingerprint.

Cite this